Adi Gilboa-Geffen

Harvard molecular biologist specializing in immunology, Dr. Gilboa-Geffen has extensive experience in Oligonucleotide therapeutic research. Her work has focused on therapeutic treatment of triple negative breast cancer, and she successfully led therapeutic constructs from IBD and Alzheimer’s disease. She has a PhD with Honors from the Hebrew University in Jerusalem, and did her post-doctoral training at Bonn University and Harvard Medical School.